Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1994 Jan;7(1):117–140. doi: 10.1128/cmr.7.1.117

Update on clinical significance of coagulase-negative staphylococci.

W E Kloos 1, T L Bannerman 1
PMCID: PMC358308  PMID: 8118787

Abstract

The clinical significance of coagulase-negative Staphylococcus species (CNS) continues to increase as strategies in medical practice lead to more invasive procedures. Hospitalized patients that are immunocompromised and/or suffering from chronic diseases are the most vulnerable to infection. Since CNS are widespread on the human body and are capable of producing very large populations, distinguishing the etiologic agent(s) from contaminating flora is a serious challenge. For this reason, culture identification should proceed to the species and strain levels. A much stronger case can be made for the identification of a CNS etiologic agent if the same strain is repeatedly isolated from a series of specimens as opposed to the isolation of different strains of one or more species. Strain identity initially can be based on colony morphology, and then one or more molecular approaches can be used to gain information on the genotype. Many of the CNS species are commonly resistant to antibiotics that are being indicated for staphylococcal infections, with the exception of vancomycin. The widespread use of antibiotics in hospitals has provided a reservoir of antibiotic-resistant genes. The main focus on mechanisms of pathogenesis has been with foreign body infections and the role of specific adhesins and slime produced by Staphylococcus epidermidis. Slime can reduce the immune response and opsonophagocytosis, thereby interfering with host defense mechanisms. As we become more aware of the various strategies used by CNS, we will be in a better position to compromise their defense mechanisms and improve treatment.

Full text

PDF
117

Images in this article

125Image
on p.125
127Image
on p.127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge K. E. In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents. Antimicrob Agents Chemother. 1992 Apr;36(4):851–853. doi: 10.1128/aac.36.4.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen R. C., Stjernholm R. L., Steele R. H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972 May 26;47(4):679–684. doi: 10.1016/0006-291x(72)90545-1. [DOI] [PubMed] [Google Scholar]
  3. Anderson J. D., Clarke A. M., Anderson M. E., Isaac-Renton J. L., McLoughlin M. G. Urinary tract infections due to Staphylococcus saprophyticus biotype 3. Can Med Assoc J. 1981 Feb 15;124(4):415–418. [PMC free article] [PubMed] [Google Scholar]
  4. Archer G. L. Coagulase-negative staphylococci in blood cultures: the clinician's dilemma. Infect Control. 1985 Dec;6(12):477–478. doi: 10.1017/s019594170006358x. [DOI] [PubMed] [Google Scholar]
  5. Archer G. L., Pennell E. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob Agents Chemother. 1990 Sep;34(9):1720–1724. doi: 10.1128/aac.34.9.1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Archer G. L., Scott J. Conjugative transfer genes in staphylococcal isolates from the United States. Antimicrob Agents Chemother. 1991 Dec;35(12):2500–2504. doi: 10.1128/aac.35.12.2500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Archer G. L., Vazquez G. J., Johnston J. L. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. J Infect Dis. 1980 Nov;142(5):725–731. doi: 10.1093/infdis/142.5.725. [DOI] [PubMed] [Google Scholar]
  8. Archer G. L., Vishniavsky N., Stiver H. G. Plasmid pattern analysis of Staphylococcal epidermidis isolates from patients with prosthetic valve endocarditis. Infect Immun. 1982 Feb;35(2):627–632. doi: 10.1128/iai.35.2.627-632.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Aufwerber E., Ringertz S., Ransjö U. Routine semiquantitative cultures and central venous catheter-related bacteremia. APMIS. 1991 Jul;99(7):627–630. doi: 10.1111/j.1699-0463.1991.tb01237.x. [DOI] [PubMed] [Google Scholar]
  10. BRANDT L., SWAHN B. Subacute bacterial endocarditis due to coagulase-negative Staphylococcus albus. Acta Med Scand. 1960 Feb 17;166:125–132. doi: 10.1111/j.0954-6820.1960.tb17362.x. [DOI] [PubMed] [Google Scholar]
  11. Baddour L. M., Phillips T. N., Bisno A. L. Coagulase-negative staphylococcal endocarditis. Occurrence in patients with mitral valve prolapse. Arch Intern Med. 1986 Jan;146(1):119–121. doi: 10.1001/archinte.146.1.119. [DOI] [PubMed] [Google Scholar]
  12. Bailey E. M., Constance T. D., Albrecht L. M., Rybak M. J. Coagulase-negative staphylococci: incidence, pathogenicity, and treatment in the 1990s. DICP. 1990 Jul-Aug;24(7-8):714–720. doi: 10.1177/106002809002400715. [DOI] [PubMed] [Google Scholar]
  13. Baker C. N., Stocker S. A., Culver D. H., Thornsberry C. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol. 1991 Mar;29(3):533–538. doi: 10.1128/jcm.29.3.533-538.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bandres J. C., Darouiche R. O. Staphylococcus capitis endocarditis: a new cause of an old disease. Clin Infect Dis. 1992 Jan;14(1):366–367. doi: 10.1093/clinids/14.1.366-a. [DOI] [PubMed] [Google Scholar]
  15. Bandyk D. F., Bergamini T. M., Kinney E. V., Seabrook G. R., Towne J. B. In situ replacement of vascular prostheses infected by bacterial biofilms. J Vasc Surg. 1991 May;13(5):575–583. [PubMed] [Google Scholar]
  16. Bannerman T. L., Kleeman K. T., Kloos W. E. Evaluation of the Vitek Systems Gram-Positive Identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol. 1993 May;31(5):1322–1325. doi: 10.1128/jcm.31.5.1322-1325.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bannerman T. L., Kloos W. E. Staphylococcus capitis subsp. ureolyticus subsp. nov. from human skin. Int J Syst Bacteriol. 1991 Jan;41(1):144–147. doi: 10.1099/00207713-41-1-144. [DOI] [PubMed] [Google Scholar]
  18. Bannerman T. L., Wadiak D. L., Kloos W. E. Susceptibility of Staphylococcus species and subspecies to fleroxacin. Antimicrob Agents Chemother. 1991 Oct;35(10):2135–2139. doi: 10.1128/aac.35.10.2135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bannerman T. L., Wadiak D. L., Kloos W. E. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob Agents Chemother. 1991 Sep;35(9):1919–1922. doi: 10.1128/aac.35.9.1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Barker L. P., Simpson W. A., Christensen G. D. Differential production of slime under aerobic and anaerobic conditions. J Clin Microbiol. 1990 Nov;28(11):2578–2579. doi: 10.1128/jcm.28.11.2578-2579.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Barry A. L., Pfaller M. A., Fuchs P. C. Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin. Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):243–246. doi: 10.1007/BF02098088. [DOI] [PubMed] [Google Scholar]
  22. Baumgart S., Hall S. E., Campos J. M., Polin R. A. Sepsis with coagulase-negative staphylococci in critically ill newborns. Am J Dis Child. 1983 May;137(5):461–463. doi: 10.1001/archpedi.1983.02140310043012. [DOI] [PubMed] [Google Scholar]
  23. Bergamini T. M., Bandyk D. F., Govostis D., Vetsch R., Towne J. B. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. J Vasc Surg. 1989 May;9(5):665–670. doi: 10.1067/mva.1989.vs0090665. [DOI] [PubMed] [Google Scholar]
  24. Bergman B., Wedrén H., Holm S. E. Staphylococcus saprophyticus in males with symptoms of chronic prostatitis. Urology. 1989 Nov;34(5):241–245. doi: 10.1016/0090-4295(89)90316-6. [DOI] [PubMed] [Google Scholar]
  25. Beutler B., Cerami A. The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655. doi: 10.1146/annurev.iy.07.040189.003205. [DOI] [PubMed] [Google Scholar]
  26. Bialkowska-Hobrzanska H., Harry V., Jaskot D., Hammerberg O. Typing of coagulase-negative staphylococci by Southern hybridization of chromosomal DNA fingerprints using a ribosomal RNA probe. Eur J Clin Microbiol Infect Dis. 1990 Aug;9(8):588–594. doi: 10.1007/BF01967213. [DOI] [PubMed] [Google Scholar]
  27. Bialkowska-Hobrzanska H., Jaskot D., Hammerberg O. Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates. J Clin Microbiol. 1990 Feb;28(2):269–275. doi: 10.1128/jcm.28.2.269-275.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Biavasco F., Lupidi R., Varaldo P. E. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873. Antimicrob Agents Chemother. 1992 Feb;36(2):331–338. doi: 10.1128/aac.36.2.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Bille J., Glauser M. P. In-vitro activity of temafloxacin for gram-positive pathogens. J Antimicrob Chemother. 1991 Dec;28 (Suppl 100):9–14. doi: 10.1093/jac/28.suppl_c.9. [DOI] [PubMed] [Google Scholar]
  30. Birnbaum D., Kelly M., Chow A. W. Epidemiologic typing systems for coagulase-negative staphylococci. Infect Control Hosp Epidemiol. 1991 May;12(5):319–326. doi: 10.1086/646347. [DOI] [PubMed] [Google Scholar]
  31. Bor D. H., Rose R. M., Modlin J. F., Weintraub R., Friedland G. H. Mediastinitis after cardiovascular surgery. Rev Infect Dis. 1983 Sep-Oct;5(5):885–897. doi: 10.1093/clinids/5.5.885. [DOI] [PubMed] [Google Scholar]
  32. Bowley J. A., Pickering S. J., Scantlebury A. J., Ackrill P., Jones D. M. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. J Antimicrob Chemother. 1988 Jan;21 (Suppl A):133–139. doi: 10.1093/jac/21.suppl_a.133. [DOI] [PubMed] [Google Scholar]
  33. Bowman R. A., Buck M. Staphylococcus hominis septicaemia in patients with cancer. Med J Aust. 1984 Jan 7;140(1):26–27. doi: 10.5694/j.1326-5377.1984.tb103842.x. [DOI] [PubMed] [Google Scholar]
  34. Brause B. D. Infections associated with prosthetic joints. Clin Rheum Dis. 1986 Aug;12(2):523–536. [PubMed] [Google Scholar]
  35. Brown A. L., Stephenson J. R., Baker L. R., Tabaqchali S. Recurrent CAPD peritonitis caused by coagulase-negative staphylococci: re-infection or relapse determined by clinical criteria and typing methods. J Hosp Infect. 1991 Jun;18(2):109–122. doi: 10.1016/0195-6701(91)90155-2. [DOI] [PubMed] [Google Scholar]
  36. Brown D. F., Brown L. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J Antimicrob Chemother. 1991 Feb;27(2):185–190. doi: 10.1093/jac/27.2.185. [DOI] [PubMed] [Google Scholar]
  37. Brunet F., Vedel G., Dreyfus F., Vaxelaire J. F., Giraud T., Schremmer B., Monsallier J. F. Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):145–147. doi: 10.1007/BF01963643. [DOI] [PubMed] [Google Scholar]
  38. Bryan C. S. Clinical implications of positive blood cultures. Clin Microbiol Rev. 1989 Oct;2(4):329–353. doi: 10.1128/cmr.2.4.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Caputo G. M., Archer G. L., Calderwood S. B., DiNubile M. J., Karchmer A. W. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med. 1987 Oct;83(4):619–625. doi: 10.1016/0002-9343(87)90889-8. [DOI] [PubMed] [Google Scholar]
  40. Carlos C. C., Ringertz S., Rylander M., Huovinen P., Faxelius G. Nosocomial Staphylococcus epidermidis septicaemia among very low birth weight neonates in an intensive care unit. J Hosp Infect. 1991 Nov;19(3):201–207. doi: 10.1016/0195-6701(91)90224-v. [DOI] [PubMed] [Google Scholar]
  41. Carson C. C., McGraw V. D., Zwadyk P. Bacterial prostatitis caused by Staphylococcus saprophyticus. Urology. 1982 Jun;19(6):576–578. doi: 10.1016/0090-4295(82)90002-4. [DOI] [PubMed] [Google Scholar]
  42. Chin N. X., Neu H. C. In vitro activity of LY264826 compared to other glycopeptides and daptomycin. Diagn Microbiol Infect Dis. 1991 Mar-Apr;14(2):181–184. doi: 10.1016/0732-8893(91)90056-l. [DOI] [PubMed] [Google Scholar]
  43. Chomarat M., Espinouse D., Flandrois J. P. Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. J Antimicrob Chemother. 1991 Apr;27(4):475–480. doi: 10.1093/jac/27.4.475. [DOI] [PubMed] [Google Scholar]
  44. Choo M. H., Holmes D. R., Jr, Gersh B. J., Maloney J. D., Merideth J., Pluth J. R., Trusty J. Permanent pacemaker infections: characterization and management. Am J Cardiol. 1981 Sep;48(3):559–564. doi: 10.1016/0002-9149(81)90088-6. [DOI] [PubMed] [Google Scholar]
  45. Christensen G. D., Parisi J. T., Bisno A. L., Simpson W. A., Beachey E. H. Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol. 1983 Aug;18(2):258–269. doi: 10.1128/jcm.18.2.258-269.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Christensen G. D., Simpson W. A., Bisno A. L., Beachey E. H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982 Jul;37(1):318–326. doi: 10.1128/iai.37.1.318-326.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Christensen G. D., Simpson W. A., Bisno A. L., Beachey E. H. Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun. 1983 Apr;40(1):407–410. doi: 10.1128/iai.40.1.407-410.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Christensen G. D., Simpson W. A., Younger J. J., Baddour L. M., Barrett F. F., Melton D. M., Beachey E. H. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985 Dec;22(6):996–1006. doi: 10.1128/jcm.22.6.996-1006.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Christensen G. D. The confusing and tenacious coagulase-negative staphylococci. Adv Intern Med. 1987;32:177–192. [PubMed] [Google Scholar]
  50. Clarke A. M. Prophylactic antibiotics for total hip arthroplasty--the significance of Staphylococcus epidermidis. J Antimicrob Chemother. 1979 Sep;5(5):493–495. doi: 10.1093/jac/5.5.493. [DOI] [PubMed] [Google Scholar]
  51. Cleri D. J., Corrado M. L., Seligman S. J. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis. 1980 Jun;141(6):781–786. doi: 10.1093/infdis/141.6.781. [DOI] [PubMed] [Google Scholar]
  52. Clink J., Pennington T. H. Staphylococcal whole-cell polypeptide analysis: evaluation as a taxonomic and typing tool. J Med Microbiol. 1987 Feb;23(1):41–44. doi: 10.1099/00222615-23-1-41. [DOI] [PubMed] [Google Scholar]
  53. Colleen S., Hovelius B., Wieslander A., Mårdh P. A. Surface properties of Staphylococcus saprophyticus and Staphylococcus epidermidis as studied by adherence tests and two-polymer, aqueous phase systems. Acta Pathol Microbiol Scand B. 1979 Dec;87(6):321–328. doi: 10.1111/j.1699-0463.1979.tb02446.x. [DOI] [PubMed] [Google Scholar]
  54. Courtiss E. H., Goldwyn R. M., Anastasi G. W. The fate of breast implants with infections around them. Plast Reconstr Surg. 1979 Jun;63(6):812–816. [PubMed] [Google Scholar]
  55. Dan M., Marien G. J., Goldsand G. Endocarditis caused by Staphylococcus warneri on a normal aortic valve following vasectomy. Can Med Assoc J. 1984 Aug 1;131(3):211–213. [PMC free article] [PubMed] [Google Scholar]
  56. De Buyser M. L., Morvan A., Grimont F., el Solh N. Characterization of Staphylococcus species by ribosomal RNA gene restriction patterns. J Gen Microbiol. 1989 Apr;135(4):989–999. doi: 10.1099/00221287-135-4-989. [DOI] [PubMed] [Google Scholar]
  57. Deighton M., Pearson S., Capstick J., Spelman D., Borland R. Phenotypic variation of Staphylococcus epidermidis isolated from a patient with native valve endocarditis. J Clin Microbiol. 1992 Sep;30(9):2385–2390. doi: 10.1128/jcm.30.9.2385-2390.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Denyer S. P., Davies M. C., Evans J. A., Finch R. G., Smith D. G., Wilcox M. H., Williams P. Influence of carbon dioxide on the surface characteristics and adherence potential of coagulase-negative staphylococci. J Clin Microbiol. 1990 Aug;28(8):1813–1817. doi: 10.1128/jcm.28.8.1813-1817.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Dinarello C. A. Interleukin-1 and its biologically related cytokines. Adv Immunol. 1989;44:153–205. doi: 10.1016/s0065-2776(08)60642-2. [DOI] [PubMed] [Google Scholar]
  60. Drewry D. T., Galbraith L., Wilkinson B. J., Wilkinson S. G. Staphylococcal slime: a cautionary tale. J Clin Microbiol. 1990 Jun;28(6):1292–1296. doi: 10.1128/jcm.28.6.1292-1296.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Driebe W. T., Jr, Mandelbaum S., Forster R. K., Schwartz L. K., Culbertson W. W. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986 Apr;93(4):442–448. doi: 10.1016/s0161-6420(86)33722-9. [DOI] [PubMed] [Google Scholar]
  62. Dryden M. S., Talsania H. G., Martin S., Cunningham M., Richardson J. F., Cookson B., Marples R. R., Phillips I. Evaluation of methods for typing coagulase-negative staphylococci. J Med Microbiol. 1992 Aug;37(2):109–117. doi: 10.1099/00222615-37-2-109. [DOI] [PubMed] [Google Scholar]
  63. Dryden M. S., Talsania H., McCann M., Cookson B. D., Phillips I. The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. Epidemiol Infect. 1992 Aug;109(1):97–112. [PMC free article] [PubMed] [Google Scholar]
  64. Endl J., Seidl H. P., Fiedler F., Schleifer K. H. Chemical composition and structure of cell wall teichoic acids of staphylococci. Arch Microbiol. 1983 Sep;135(3):215–223. doi: 10.1007/BF00414483. [DOI] [PubMed] [Google Scholar]
  65. Erwin M. E., Jones R. N., Barrett M. S., Briggs B. M., Johnson D. M. In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin. Antimicrob Agents Chemother. 1991 May;35(5):929–937. doi: 10.1128/aac.35.5.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Etienne J., Renaud F., Bes M., Brun Y., Greenland T. B., Freney J., Fleurette J. Instability of characteristics amongst coagulase-negative staphylococci causing endocarditis. J Med Microbiol. 1990 Jun;32(2):115–122. doi: 10.1099/00222615-32-2-115. [DOI] [PubMed] [Google Scholar]
  67. Evans R. C., Holmes C. J. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother. 1987 Jun;31(6):889–894. doi: 10.1128/aac.31.6.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Eykyn S. J., Gransden W. R., Phillips I. The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother. 1990 Apr;25 (Suppl 100):41–58. doi: 10.1093/jac/25.suppl_c.41. [DOI] [PubMed] [Google Scholar]
  69. Ferguson D. A., Jr, Veringa E. M., Mayberry W. R., Overbeek B. P., Lambe D. W., Jr, Verhoef J. Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes. Microbios. 1992;69(278):53–65. [PubMed] [Google Scholar]
  70. Ferguson K. P., Lambe D. W., Jr, Keplinger J. L., Kalbfleisch J. H. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can J Microbiol. 1991 Sep;37(9):722–724. doi: 10.1139/m91-124. [DOI] [PubMed] [Google Scholar]
  71. Ferreirós C. M., Souto M. J., Criado M. T., Suárez P. Phage typing and phage induction in carrier and invasive Staphylococcus epidermidis isolates. J Hosp Infect. 1991 Aug;18(4):293–299. doi: 10.1016/0195-6701(91)90186-c. [DOI] [PubMed] [Google Scholar]
  72. Fleer A., Senders R. C., Visser M. R., Bijlmer R. P., Gerards L. J., Kraaijeveld C. A., Verhoef J. Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis. Pediatr Infect Dis. 1983 Nov-Dec;2(6):426–431. doi: 10.1097/00006454-198311000-00003. [DOI] [PubMed] [Google Scholar]
  73. Fleer A., Verhoef J. An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci. J Invest Surg. 1989;2(4):391–396. doi: 10.3109/08941938909018264. [DOI] [PubMed] [Google Scholar]
  74. Fleurette J., Bès M., Brun Y., Freney J., Forey F., Coulet M., Reverdy M. E., Etienne J. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol. 1989 Feb;140(2):107–118. doi: 10.1016/0923-2508(89)90044-2. [DOI] [PubMed] [Google Scholar]
  75. Floyd-Reising S., Hindler J. A., Young L. S. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents. Antimicrob Agents Chemother. 1987 Apr;31(4):640–642. doi: 10.1128/aac.31.4.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Flynn P. M., Shenep J. L., Stokes D. C., Barrett F. F. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J. 1987 Aug;6(8):729–734. doi: 10.1097/00006454-198708000-00007. [DOI] [PubMed] [Google Scholar]
  77. Forstall G. J., Knapp C. C., Washington J. A. Activity of new quinolones against ciprofloxacin-resistant staphylococci. Antimicrob Agents Chemother. 1991 Aug;35(8):1679–1681. doi: 10.1128/aac.35.8.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Freeman J., Platt R., Epstein M. F., Smith N. E., Sidebottom D. G., Goldmann D. A. Birth weight and length of stay as determinants of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: potential for confounding. Am J Epidemiol. 1990 Dec;132(6):1130–1140. doi: 10.1093/oxfordjournals.aje.a115756. [DOI] [PubMed] [Google Scholar]
  79. Freeman J., Platt R., Sidebottom D. G., Leclair J. M., Epstein M. F., Goldmann D. A. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA. 1987 Nov 13;258(18):2548–2552. [PubMed] [Google Scholar]
  80. Freeman R., Goodfellow M., Ward A. C., Hudson S. J., Gould F. K., Lightfoot N. F. Epidemiological typing of coagulase-negative staphylococci by pyrolysis mass spectrometry. J Med Microbiol. 1991 May;34(5):245–248. doi: 10.1099/00222615-34-5-245. [DOI] [PubMed] [Google Scholar]
  81. Freeman R., Gould F. K., Wilkinson R., Ward A. C., Lightfoot N. F., Sisson P. R. Rapid inter-strain comparison by pyrolysis mass spectrometry of coagulase-negative staphylococci from persistent CAPD peritonitis. Epidemiol Infect. 1991 Apr;106(2):239–246. doi: 10.1017/s095026880004838x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Froggatt J. W., Johnston J. L., Galetto D. W., Archer G. L. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother. 1989 Apr;33(4):460–466. doi: 10.1128/aac.33.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Fu K. P., Lafredo S. C., Foleno B., Isaacson D. M., Barrett J. F., Tobia A. J., Rosenthale M. E. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother. 1992 Apr;36(4):860–866. doi: 10.1128/aac.36.4.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. GALLAGHER D. J., MONTGOMERIE J. Z., NORTH J. D. ACUTE INFECTIONS OF THE URINARY TRACT AND THE URETHRAL SYNDROME IN GENERAL PRACTICE. Br Med J. 1965 Mar 6;1(5435):622–626. doi: 10.1136/bmj.1.5435.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Gatermann S., John J., Marre R. Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect Immun. 1989 Jan;57(1):110–116. doi: 10.1128/iai.57.1.110-116.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Gatermann S., Kreft B., Marre R., Wanner G. Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect Immun. 1992 Mar;60(3):1055–1060. doi: 10.1128/iai.60.3.1055-1060.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. George R. C., Ball L. C., Norbury P. B. Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK. J Antimicrob Chemother. 1990 Dec;26 (Suppl F):145–156. doi: 10.1093/jac/26.suppl_f.145. [DOI] [PubMed] [Google Scholar]
  88. George R., Leibrock L., Epstein M. Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg. 1979 Dec;51(6):804–811. doi: 10.3171/jns.1979.51.6.0804. [DOI] [PubMed] [Google Scholar]
  89. Gill V. J., Selepak S. T., Williams E. C. Species identification and antibiotic susceptibilities of coagulase-negative staphylococci isolated from clinical specimens. J Clin Microbiol. 1983 Dec;18(6):1314–1319. doi: 10.1128/jcm.18.6.1314-1319.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Glimåker M., Granert C., Krook A. Septicemia caused by Staphylococcus saprophyticus. Scand J Infect Dis. 1988;20(3):347–348. doi: 10.3109/00365548809032464. [DOI] [PubMed] [Google Scholar]
  91. Goering R. V., Duensing T. D. Rapid field inversion gel electrophoresis in combination with an rRNA gene probe in the epidemiological evaluation of staphylococci. J Clin Microbiol. 1990 Mar;28(3):426–429. doi: 10.1128/jcm.28.3.426-429.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Goering R. V., Winters M. A. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol. 1992 Mar;30(3):577–580. doi: 10.1128/jcm.30.3.577-580.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Gokal R. Peritonitis in continuous ambulatory peritoneal dialysis. J Antimicrob Chemother. 1982 Jun;9(6):417–420. doi: 10.1093/jac/9.6.417. [DOI] [PubMed] [Google Scholar]
  94. Goldenring J. M., Fried D. C., Tames S. M. Staphylococcus saprophyticus urinary tract infection in a sexually abused child. Pediatr Infect Dis J. 1988 Jan;7(1):73–74. doi: 10.1097/00006454-198801000-00020. [DOI] [PubMed] [Google Scholar]
  95. Goldenring J. M. Urinary tract infection with Staphylococcus saprophyticus. J Adolesc Health Care. 1986 Nov;7(6):417–418. doi: 10.1016/s0197-0070(86)80247-9. [DOI] [PubMed] [Google Scholar]
  96. Goldstein F. W., Coutrot A., Sieffer A., Acar J. F. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother. 1990 May;34(5):899–900. doi: 10.1128/aac.34.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Golledge C. L. Staphylococcus saprophyticus bacteremia. J Infect Dis. 1988 Jan;157(1):215–215. doi: 10.1093/infdis/157.1.215. [DOI] [PubMed] [Google Scholar]
  98. Gray E. D., Peters G., Verstegen M., Regelmann W. E. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet. 1984 Feb 18;1(8373):365–367. doi: 10.1016/s0140-6736(84)90413-6. [DOI] [PubMed] [Google Scholar]
  99. Grosserode M. H., Wenzel R. P. The continuing importance of staphylococci as major hospital pathogens. J Hosp Infect. 1991 Sep;19 (Suppl B):3–17. doi: 10.1016/0195-6701(91)90197-g. [DOI] [PubMed] [Google Scholar]
  100. Gruer L. D., Bartlett R., Ayliffe G. A. Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother. 1984 Jun;13(6):577–583. doi: 10.1093/jac/13.6.577. [DOI] [PubMed] [Google Scholar]
  101. Hamilton-Miller J. M. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci. J Antimicrob Chemother. 1992 Feb;29(2):141–147. doi: 10.1093/jac/29.2.141. [DOI] [PubMed] [Google Scholar]
  102. Harding I., Garaud J. J. Teicoplanin in the treatment of infections caused by coagulase-negative staphylococci. J Antimicrob Chemother. 1988 Jan;21 (Suppl A):93–103. doi: 10.1093/jac/21.suppl_a.93. [DOI] [PubMed] [Google Scholar]
  103. Hedman P., Ringertz O. Urinary tract infections caused by Staphylococcus saprophyticus. A matched case control study. J Infect. 1991 Sep;23(2):145–153. doi: 10.1016/0163-4453(91)92045-7. [DOI] [PubMed] [Google Scholar]
  104. Herwaldt L. A., Boyken L. D., Pfaller M. A. Biotyping of coagulase-negative staphylococci. 108 isolates from nosocomial bloodstream infections. Diagn Microbiol Infect Dis. 1990 Nov-Dec;13(6):461–466. doi: 10.1016/0732-8893(90)90077-9. [DOI] [PubMed] [Google Scholar]
  105. Herwaldt L., Boyken L., Pfaller M. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1007–1012. doi: 10.1007/BF01984921. [DOI] [PubMed] [Google Scholar]
  106. Hjelm E., Lundell-Etherden I. Slime production by Staphylococcus saprophyticus. Infect Immun. 1991 Jan;59(1):445–448. doi: 10.1128/iai.59.1.445-448.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Hjelm E., Schwan A., Lundell-Etherden I., Sandberg T. Antibody response to Staphylococcus saprophyticus in urinary tract infection. Scand J Infect Dis. 1990;22(5):557–560. doi: 10.3109/00365549009027096. [DOI] [PubMed] [Google Scholar]
  108. Hodinka R. L., Jack-Wait K., Gilligan P. H. Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Eur J Clin Microbiol. 1987 Feb;6(1):103–108. doi: 10.1007/BF02097212. [DOI] [PubMed] [Google Scholar]
  109. Hogt A. H., Dankert J., Hulstaert C. E., Feijen J. Cell surface characteristics of coagulase-negative staphylococci and their adherence to fluorinated poly(ethylenepropylene). Infect Immun. 1986 Jan;51(1):294–301. doi: 10.1128/iai.51.1.294-301.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Hogt A. H., Dankert J., de Vries J. A., Feijen J. Adhesion of coagulase-negative staphylococci to biomaterials. J Gen Microbiol. 1983 Sep;129(9):2959–2968. doi: 10.1099/00221287-129-9-2959. [DOI] [PubMed] [Google Scholar]
  111. Huang M. B., Baker C. N., Banerjee S., Tenover F. C. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol. 1992 Dec;30(12):3243–3248. doi: 10.1128/jcm.30.12.3243-3248.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Hussain M., Collins C., Hastings J. G., White P. J. Radiochemical assay to measure the biofilm produced by coagulase-negative staphylococci on solid surfaces and its use to quantitate the effects of various antibacterial compounds on the formation of the biofilm. J Med Microbiol. 1992 Jul;37(1):62–69. doi: 10.1099/00222615-37-1-62. [DOI] [PubMed] [Google Scholar]
  113. Hussain M., Hastings J. G., White P. J. A chemically defined medium for slime production by coagulase-negative staphylococci. J Med Microbiol. 1991 Mar;34(3):143–147. doi: 10.1099/00222615-34-3-143. [DOI] [PubMed] [Google Scholar]
  114. Hussain M., Hastings J. G., White P. J. Comparison of cell-wall teichoic acid with high-molecular-weight extracellular slime material from Staphylococcus epidermidis. J Med Microbiol. 1992 Dec;37(6):368–375. doi: 10.1099/00222615-37-6-368. [DOI] [PubMed] [Google Scholar]
  115. Hussain M., Hastings J. G., White P. J. Isolation and composition of the extracellular slime made by coagulase-negative staphylococci in a chemically defined medium. J Infect Dis. 1991 Mar;163(3):534–541. doi: 10.1093/infdis/163.3.534. [DOI] [PubMed] [Google Scholar]
  116. Hussain M., Wilcox M. H., White P. J., Faulkner M. K., Spencer R. C. Importance of medium and atmosphere type to both slime production and adherence by coagulase-negative staphylococci. J Hosp Infect. 1992 Mar;20(3):173–184. doi: 10.1016/0195-6701(92)90085-z. [DOI] [PubMed] [Google Scholar]
  117. Hájek V., Ludwig W., Schleifer K. H., Springer N., Zitzelsberger W., Kroppenstedt R. M., Kocur M. Staphylococcus muscae, a new species isolated from flies. Int J Syst Bacteriol. 1992 Jan;42(1):97–101. doi: 10.1099/00207713-42-1-97. [DOI] [PubMed] [Google Scholar]
  118. Hébert G. A., Cooksey R. C., Clark N. C., Hill B. C., Jarvis W. R., Thornsberry C. Biotyping coagulase-negative staphylococci. J Clin Microbiol. 1988 Oct;26(10):1950–1956. doi: 10.1128/jcm.26.10.1950-1956.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Hébert G. A. Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi. J Clin Microbiol. 1990 Nov;28(11):2425–2431. doi: 10.1128/jcm.28.11.2425-2431.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Igimi S., Takahashi E., Mitsuoka T. Staphylococcus schleiferi subsp. coagulans subsp. nov., isolated from the external auditory meatus of dogs with external ear otitis. Int J Syst Bacteriol. 1990 Oct;40(4):409–411. doi: 10.1099/00207713-40-4-409. [DOI] [PubMed] [Google Scholar]
  121. Izard N. C., Hächler H., Grehn M., Kayser F. H. Ribotyping of coagulase-negative staphylococci with special emphasis on intraspecific typing of Staphylococcus epidermidis. J Clin Microbiol. 1992 Apr;30(4):817–823. doi: 10.1128/jcm.30.4.817-823.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Jansen B., Schumacher-Perdreau F., Peters G., Pulverer G. New aspects in the pathogenesis and prevention of polymer-associated foreign-body infections caused by coagulase-negative staphylococci. J Invest Surg. 1989;2(4):361–380. doi: 10.3109/08941938909018262. [DOI] [PubMed] [Google Scholar]
  123. Jansen B., Schumacher-Perdreau F., Peters G., Reinhold G., Schönemann J. Native valve endocarditis caused by Staphylococcus simulans. Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):268–269. doi: 10.1007/BF02098097. [DOI] [PubMed] [Google Scholar]
  124. Jarvis W. R., Martone W. J. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992 Apr;29 (Suppl A):19–24. doi: 10.1093/jac/29.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  125. Jean-Pierre H., Darbas H., Jean-Roussenq A., Boyer G. Pathogenicity in two cases of Staphylococcus schleiferi, a recently described species. J Clin Microbiol. 1989 Sep;27(9):2110–2111. doi: 10.1128/jcm.27.9.2110-2111.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Jenssen W. D., Thakker-Varia S., Dubin D. T., Weinstein M. P. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother. 1987 Jun;31(6):883–888. doi: 10.1128/aac.31.6.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. John J. F., Jr, Gramling P. K., O'Dell N. M. Species identification of coagulase-negative staphylococci from urinary tract isolates. J Clin Microbiol. 1978 Oct;8(4):435–437. doi: 10.1128/jcm.8.4.435-437.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Johnson A. P., Uttley A. H., Woodford N., George R. C. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990 Jul;3(3):280–291. doi: 10.1128/cmr.3.3.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Jones R. N., Erwin M. E., Barrett M. S., Johnson D. M., Briggs B. M. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems. Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):301–309. doi: 10.1016/0732-8893(91)90021-7. [DOI] [PubMed] [Google Scholar]
  130. Jones R. N., Goldstein F. W., Zhou X. Y. Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States. Antimicrob Agents Chemother. 1991 Mar;35(3):584–586. doi: 10.1128/aac.35.3.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Jones R. N., Pfaller M. A., Allen S. D., Gerlach E. H., Fuchs P. C., Aldridge K. E. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):361–364. doi: 10.1016/0732-8893(91)90029-f. [DOI] [PubMed] [Google Scholar]
  132. KASS E. H. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56–64. [PubMed] [Google Scholar]
  133. Kamath U., Singer C., Isenberg H. D. Clinical significance of Staphylococcus warneri bacteremia. J Clin Microbiol. 1992 Feb;30(2):261–264. doi: 10.1128/jcm.30.2.261-264.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Kamme C., Lindberg L. Aerobic and anaerobic bacteria in deep infections after total hip arthroplasty: differential diagnosis between infectious and non-infectious loosening. Clin Orthop Relat Res. 1981 Jan-Feb;(154):201–207. [PubMed] [Google Scholar]
  135. Kanda K., Suzuki E., Hiramatsu K., Oguri T., Miura H., Ezaki T., Yokota T. Identification of a methicillin-resistant strain of Staphylococcus caprae from a human clinical specimen. Antimicrob Agents Chemother. 1991 Jan;35(1):174–176. doi: 10.1128/aac.35.1.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Karthigasu K. T., Bowman R. A., Grove D. I. Vertebral osteomyelitis due to Staphylococcus warneri. Ann Rheum Dis. 1986 Dec;45(12):1029–1030. doi: 10.1136/ard.45.12.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Kenny M. T., Mayer G. D., Dulworth J. K., Brackman M. A., Farrar K. Evaluation of the teicoplanin broth microdilution and disk diffusion susceptibility tests and recommended interpretive criteria. Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):609–612. doi: 10.1016/0732-8893(90)90038-w. [DOI] [PubMed] [Google Scholar]
  138. King A., Boothman C., Phillips I. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins. Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):677–685. doi: 10.1007/BF01964272. [DOI] [PubMed] [Google Scholar]
  139. Kleeman K. T., Bannerman T. L., Kloos W. E. Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J Clin Microbiol. 1993 May;31(5):1318–1321. doi: 10.1128/jcm.31.5.1318-1321.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Kloos W. E., George C. G. Identification of Staphylococcus species and subspecies with the MicroScan Pos ID and Rapid Pos ID panel systems. J Clin Microbiol. 1991 Apr;29(4):738–744. doi: 10.1128/jcm.29.4.738-744.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Kloos W. E., Musselwhite M. S. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol. 1975 Sep;30(3):381–385. doi: 10.1128/am.30.3.381-395.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Kloos W. E. Systematics and the natural history of staphylococci 1. Soc Appl Bacteriol Symp Ser. 1990;19:25S–37S. doi: 10.1111/j.1365-2672.1990.tb01795.x. [DOI] [PubMed] [Google Scholar]
  143. Kloos W. E., Wolfshohl J. F. Staphylococcus cohnii subspecies: Staphylococcus cohnii subsp. cohnii subsp. nov. and Staphylococcus cohnii subsp. urealyticum subsp. nov. Int J Syst Bacteriol. 1991 Apr;41(2):284–289. doi: 10.1099/00207713-41-2-284. [DOI] [PubMed] [Google Scholar]
  144. Kluge R. M., Calia F. M., McLaughlin J. S., Hornick R. B. Sources of contamination in open heart surgery. JAMA. 1974 Dec 4;230(10):1415–1418. [PubMed] [Google Scholar]
  145. Kojima Y., Tojo M., Goldmann D. A., Tosteson T. D., Pier G. B. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis. 1990 Aug;162(2):435–441. doi: 10.1093/infdis/162.2.435. [DOI] [PubMed] [Google Scholar]
  146. Kotilainen P., Huovinen P., Eerola E. Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J Clin Microbiol. 1991 Feb;29(2):315–322. doi: 10.1128/jcm.29.2.315-322.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Kotilainen P., Nikoskelainen J., Huovinen P. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis. 1990 Jan;161(1):41–44. doi: 10.1093/infdis/161.1.41. [DOI] [PubMed] [Google Scholar]
  148. Kraus E. S., Spector D. A. Characteristics and sequelae of peritonitis in diabetics and nondiabetics receiving chronic intermittent peritoneal dialysis. Medicine (Baltimore) 1983 Jan;62(1):52–57. doi: 10.1097/00005792-198301000-00005. [DOI] [PubMed] [Google Scholar]
  149. Krieger J. N., McGonagle L. A. Diagnostic considerations and interpretation of microbiological findings for evaluation of chronic prostatitis. J Clin Microbiol. 1989 Oct;27(10):2240–2244. doi: 10.1128/jcm.27.10.2240-2244.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Lambe D. W., Jr, Ferguson K. P., Keplinger J. L., Gemmell C. G., Kalbfleisch J. H. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can J Microbiol. 1990 Jul;36(7):455–463. doi: 10.1139/m90-080. [DOI] [PubMed] [Google Scholar]
  151. Lambe D. W., Jr, Ferguson K. P., Mayberry-Carson K. J., Tober-Meyer B., Costerton J. W. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthop Relat Res. 1991 May;(266):285–294. [PubMed] [Google Scholar]
  152. Latham R. H., Running K., Stamm W. E. Urinary tract infections in young adult women caused by Staphylococcus saprophyticus. JAMA. 1983 Dec 9;250(22):3063–3066. [PubMed] [Google Scholar]
  153. Lee W., Carpenter R. J., Phillips L. E., Faro S. Pyelonephritis and sepsis due to Staphylococcus saprophyticus. J Infect Dis. 1987 May;155(5):1079–1080. doi: 10.1093/infdis/155.5.1079-a. [DOI] [PubMed] [Google Scholar]
  154. Leighton P. M., Little J. A. Identification of coagulase-negative Staphylococci isolated from urinary tract infections. Am J Clin Pathol. 1986 Jan;85(1):92–95. doi: 10.1093/ajcp/85.1.92. [DOI] [PubMed] [Google Scholar]
  155. Leitner F., Pursiano T. A., Buck R. E., Tsai Y. H., Chisholm D. R., Misiek M., Desiderio J. V., Kessler R. E. BMY 28100, a new oral cephalosporin. Antimicrob Agents Chemother. 1987 Feb;31(2):238–243. doi: 10.1128/aac.31.2.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Lina B., Celard M., Vandenesch F., Ribier A., Delahaye J. P., Etienne J. Infective endocarditis due to Staphylococcus capitis. Clin Infect Dis. 1992 Jul;15(1):173–174. doi: 10.1093/clinids/15.1.173. [DOI] [PubMed] [Google Scholar]
  157. Liñares J., Sitges-Serra A., Garau J., Pérez J. L., Martín R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol. 1985 Mar;21(3):357–360. doi: 10.1128/jcm.21.3.357-360.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Low D. E., McGeer A., Poon R. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrob Agents Chemother. 1989 Apr;33(4):585–588. doi: 10.1128/aac.33.4.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Low D. E., Schmidt B. K., Kirpalani H. M., Moodie R., Kreiswirth B., Matlow A., Ford-Jones E. L. An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients. Pediatrics. 1992 Apr;89(4 Pt 2):696–700. [PubMed] [Google Scholar]
  160. Ludlam H. A., Noble W. C., Marples R. R., Phillips I. The evaluation of a typing scheme for coagulase-negative staphylococci suitable for epidemiological studies. J Med Microbiol. 1989 Nov;30(3):161–165. doi: 10.1099/00222615-30-3-161. [DOI] [PubMed] [Google Scholar]
  161. Ludwicka A., Jansen B., Wadström T., Pulverer G. Attachment of staphylococci to various synthetic polymers. Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Apr;256(4):479–489. doi: 10.1016/s0174-3031(84)80024-4. [DOI] [PubMed] [Google Scholar]
  162. Mabeck C. E. Significance of coagulase-negative staphylococcal bacteriuria. Lancet. 1969 Nov 29;2(7631):1150–1152. doi: 10.1016/s0140-6736(69)92481-7. [DOI] [PubMed] [Google Scholar]
  163. Maggs A. F., Pennington T. H. Temporal study of staphylococcal species on the skin of human subjects in isolation and clonal analysis of Staphylococcus capitis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Microbiol. 1989 Dec;27(12):2627–2632. doi: 10.1128/jcm.27.12.2627-2632.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Maki D. G., Weise C. E., Sarafin H. W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977 Jun 9;296(23):1305–1309. doi: 10.1056/NEJM197706092962301. [DOI] [PubMed] [Google Scholar]
  165. Males B. M., Bartholomew W. R., Amsterdam D. Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis. J Clin Microbiol. 1985 Feb;21(2):255–257. doi: 10.1128/jcm.21.2.255-257.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Marrie T. J., Kwan C., Noble M. A., West A., Duffield L. Staphylococcus saprophyticus as a cause of urinary tract infections. J Clin Microbiol. 1982 Sep;16(3):427–431. doi: 10.1128/jcm.16.3.427-431.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Martin M. A., Pfaller M. A., Wenzel R. P. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med. 1989 Jan 1;110(1):9–16. doi: 10.7326/0003-4819-110-1-9. [DOI] [PubMed] [Google Scholar]
  168. Maskell J. P., Sefton A. M., Williams J. D. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother. 1990 Jan;25 (Suppl A):19–24. doi: 10.1093/jac/25.suppl_a.19. [DOI] [PubMed] [Google Scholar]
  169. Masur H., Johnson W. D., Jr Prosthetic valve endocarditis. J Thorac Cardiovasc Surg. 1980 Jul;80(1):31–37. [PubMed] [Google Scholar]
  170. Mayberry-Carson K. J., Tober-Meyer B., Gill L. R., Lambe D. W., Jr, Mayberry W. R. Effect of ciprofloxacin on subcutaneous abscesses induced with Staphylococcus epidermidis and a foreign body implant in the mouse. Microbios. 1988;54(218):45–59. [PubMed] [Google Scholar]
  171. McCabe W. R., Treadwell T. L., De Maria A., Jr Pathophysiology of bacteremia. Am J Med. 1983 Jul 28;75(1B):7–18. doi: 10.1016/0002-9343(83)90067-0. [DOI] [PubMed] [Google Scholar]
  172. McCarthy J. S., Stanley P. A., Mayall B. A case of Staphylococcus simulans endocarditis affecting a native heart valve. J Infect. 1991 Mar;22(2):211–212. doi: 10.1016/0163-4453(91)91899-9. [DOI] [PubMed] [Google Scholar]
  173. McLean R. J., Nickel J. C., Noakes V. C., Costerton J. W. An in vitro ultrastructural study of infectious kidney stone genesis. Infect Immun. 1985 Sep;49(3):805–811. doi: 10.1128/iai.49.3.805-811.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Meares E. M., Jr Prostatitis syndromes: new perspectives about old woes. J Urol. 1980 Feb;123(2):141–147. doi: 10.1016/s0022-5347(17)55828-0. [DOI] [PubMed] [Google Scholar]
  175. Meares E. M., Stamey T. A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968 Mar;5(5):492–518. [PubMed] [Google Scholar]
  176. Mickelsen P. A., Plorde J. J., Gordon K. P., Hargiss C., McClure J., Schoenknecht F. D., Condie F., Tenover F. C., Tompkins L. S. Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis. J Infect Dis. 1985 Jul;152(1):50–58. doi: 10.1093/infdis/152.1.50. [DOI] [PubMed] [Google Scholar]
  177. Morris I. M., Mattingly P. C., Gostelow B. E. Coagulase-negative Staphylococcus as a cause of joint infection. Br J Rheumatol. 1986 Nov;25(4):414–415. doi: 10.1093/rheumatology/25.4.414. [DOI] [PubMed] [Google Scholar]
  178. Muller E., Hübner J., Gutierrez N., Takeda S., Goldmann D. A., Pier G. B. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun. 1993 Feb;61(2):551–558. doi: 10.1128/iai.61.2.551-558.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Murakami K., Minamide W., Wada K., Nakamura E., Teraoka H., Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol. 1991 Oct;29(10):2240–2244. doi: 10.1128/jcm.29.10.2240-2244.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Muratani T., Inoue M., Mitsuhashi S. In vitro activity of T-3761, a new fluoroquinolone. Antimicrob Agents Chemother. 1992 Oct;36(10):2293–2303. doi: 10.1128/aac.36.10.2293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Musser J. M., Schlievert P. M., Chow A. W., Ewan P., Kreiswirth B. N., Rosdahl V. T., Naidu A. S., Witte W., Selander R. K. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A. 1990 Jan;87(1):225–229. doi: 10.1073/pnas.87.1.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Myrvik Q. N., Wagner W., Barth E., Wood P., Gristina A. G. Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages. J Invest Surg. 1989;2(4):381–389. doi: 10.3109/08941938909018263. [DOI] [PubMed] [Google Scholar]
  183. Mårdh P. A., Colleen S., Hovelius B. Attachment of bacteria to exfoliated cells from the urogenital tract. Invest Urol. 1979 Mar;16(5):322–326. [PubMed] [Google Scholar]
  184. Neu H. C., Chin N. X., Niu W. W. In vitro activity of the new glycopeptide decaplanin. Eur J Clin Microbiol Infect Dis. 1992 May;11(5):458–462. doi: 10.1007/BF01961864. [DOI] [PubMed] [Google Scholar]
  185. Ngui-Yen J. H., Bryce E. A., Porter C., Smith J. A. Evaluation of the E test by using selected gram-positive bacteria. J Clin Microbiol. 1992 Aug;30(8):2150–2152. doi: 10.1128/jcm.30.8.2150-2152.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Nickel J. C., Costerton J. W. Coagulase-negative staphylococcus in chronic prostatitis. J Urol. 1992 Feb;147(2):398–401. doi: 10.1016/s0022-5347(17)37247-6. [DOI] [PubMed] [Google Scholar]
  187. Nickel J. C., Emtage J., Costerton J. W. Ultrastructural microbial ecology of infection-induced urinary stones. J Urol. 1985 Apr;133(4):622–627. doi: 10.1016/s0022-5347(17)49116-6. [DOI] [PubMed] [Google Scholar]
  188. O'Day D. M., Jones D. B., Patrinely J., Elliott J. H. Staphylococcus epidermidis endophthalmitis. Visual outcome following noninvasive therapy. Ophthalmology. 1982 Apr;89(4):354–360. [PubMed] [Google Scholar]
  189. Ohshima Y., Schumacher-Perdreau F., Peters G., Quie P. G., Pulverer G. Antiphagocytic effect of the capsule of Staphylococcus simulans. Infect Immun. 1990 May;58(5):1350–1354. doi: 10.1128/iai.58.5.1350-1354.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Pagano L., Larocca L. M., Marra R., Pizzigallo E., Leone G. A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. Clin Infect Dis. 1992 Jan;14(1):364–365. doi: 10.1093/clinids/14.1.364. [DOI] [PubMed] [Google Scholar]
  191. Paley D., Moseley C. F., Armstrong P., Prober C. G. Primary osteomyelitis caused by coagulase-negative staphylococci. J Pediatr Orthop. 1986 Sep-Oct;6(5):622–626. doi: 10.1097/01241398-198609000-00019. [DOI] [PubMed] [Google Scholar]
  192. Parisi J. T. Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis. Microbiol Rev. 1985 Jun;49(2):126–139. doi: 10.1128/mr.49.2.126-139.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Pascual A., Fleer A., Westerdaal N. A., Verhoef J. Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. Eur J Clin Microbiol. 1986 Oct;5(5):518–522. doi: 10.1007/BF02017694. [DOI] [PubMed] [Google Scholar]
  194. Patrick C. C. Coagulase-negative staphylococci: pathogens with increasing clinical significance. J Pediatr. 1990 Apr;116(4):497–507. doi: 10.1016/s0022-3476(05)81593-8. [DOI] [PubMed] [Google Scholar]
  195. Paulsson M., Ljungh A., Wadström T. Rapid identification of fibronectin, vitronectin, laminin, and collagen cell surface binding proteins on coagulase-negative staphylococci by particle agglutination assays. J Clin Microbiol. 1992 Aug;30(8):2006–2012. doi: 10.1128/jcm.30.8.2006-2012.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Paulsson M., Petersson A. C., Ljungh A. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J Med Microbiol. 1993 Feb;38(2):96–102. doi: 10.1099/00222615-38-2-96. [DOI] [PubMed] [Google Scholar]
  197. Paulsson M., Wadström T. Vitronectin and type-I collagen binding by Staphylococcus aureus and coagulase-negative staphylococci. FEMS Microbiol Immunol. 1990 May;2(1):55–62. doi: 10.1111/j.1574-6968.1990.tb03479.x. [DOI] [PubMed] [Google Scholar]
  198. Peters G., Locci R., Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 1982 Oct;146(4):479–482. doi: 10.1093/infdis/146.4.479. [DOI] [PubMed] [Google Scholar]
  199. Peters G., Saborowski F., Locci R., Pulverer G. Investigations on staphylococcal infection of transvenous endocardial pacemaker electrodes. Am Heart J. 1984 Aug;108(2):359–365. doi: 10.1016/0002-8703(84)90625-2. [DOI] [PubMed] [Google Scholar]
  200. Pfaller M. A., Herwaldt L. A. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev. 1988 Jul;1(3):281–299. doi: 10.1128/cmr.1.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Pfau A. Bacterial prostatitis caused by Staphylococcus saprophyticus. Urology. 1983 Jan;21(1):102–103. doi: 10.1016/0090-4295(83)90141-3. [DOI] [PubMed] [Google Scholar]
  202. Phillips G., Golledge C. L. Vancomycin and teicoplanin: something old, something new. Med J Aust. 1992 Jan 6;156(1):53–57. doi: 10.5694/j.1326-5377.1992.tb126387.x. [DOI] [PubMed] [Google Scholar]
  203. Pierre J., Williamson R., Bornet M., Gutmann L. Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole. Antimicrob Agents Chemother. 1990 Sep;34(9):1691–1694. doi: 10.1128/aac.34.9.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Platt R. Quantitative definition of bacteriuria. Am J Med. 1983 Jul 28;75(1B):44–52. doi: 10.1016/0002-9343(83)90072-4. [DOI] [PubMed] [Google Scholar]
  205. Plaunt M. R., Patrick C. C. Identification of the innate human immune response to surface-exposed proteins of coagulase-negative staphylococci. J Clin Microbiol. 1991 May;29(5):857–861. doi: 10.1128/jcm.29.5.857-861.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Pulverer G., Halswick R. Coagulase-negative Staphylokokken (Staphylococcus albus) als Krankheitserreger. Dtsch Med Wochenschr. 1967 Jun 23;92(25):1141–1145. doi: 10.1055/s-0028-1103754. [DOI] [PubMed] [Google Scholar]
  207. Qadri S. M., Ueno Y., Burns J. J., Almodovar E., Rabea N. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone. Chemotherapy. 1992;38(2):99–106. doi: 10.1159/000238948. [DOI] [PubMed] [Google Scholar]
  208. Qadri S. M., Ueno Y., Frayha H. H. In vitro activity of LY281389 and comparison with erythromycin and oral beta-lactams. Chemotherapy. 1991;37(4):270–274. doi: 10.1159/000238866. [DOI] [PubMed] [Google Scholar]
  209. ROGERS H. J., PERKINS H. R. 5-Fluorouracil and mucopeptide biosynthesis by Staphylococcus aureus. Biochem J. 1960 Dec;77:448–459. doi: 10.1042/bj0770448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Rhoden D. L., Hancock G. A., Miller J. M. Numerical approach to reference identification of Staphylococcus, Stomatococcus, and Micrococcus spp. J Clin Microbiol. 1993 Mar;31(3):490–493. doi: 10.1128/jcm.31.3.490-493.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Richardson J. V., Karp R. B., Kirklin J. W., Dismukes W. E. Treatment of infective endocarditis: a 10-year comparative analysis. Circulation. 1978 Oct;58(4):589–597. doi: 10.1161/01.cir.58.4.589. [DOI] [PubMed] [Google Scholar]
  212. Rolston K. V., Nguyen H. T., Ho D. H., LeBlanc B., Bodey G. P. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents. Antimicrob Agents Chemother. 1992 Apr;36(4):879–882. doi: 10.1128/aac.36.4.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Rolston K. V., Nguyen H., Messer M. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer. Antimicrob Agents Chemother. 1990 Nov;34(11):2137–2141. doi: 10.1128/aac.34.11.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Rosdahl V. T., Gahrn-Hansen B., Møller J. K., Kjaeldgaard P. Phage-typing of coagulase-negative staphylococci. Factors influencing typability. APMIS. 1990 Apr;98(4):299–304. doi: 10.1111/j.1699-0463.1990.tb01036.x. [DOI] [PubMed] [Google Scholar]
  215. Ross J. I., Farrell A. M., Eady E. A., Cove J. H., Cunliffe W. J. Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother. 1989 Dec;24(6):851–862. doi: 10.1093/jac/24.6.851. [DOI] [PubMed] [Google Scholar]
  216. Rubin J., Rogers W. A., Taylor H. M., Everett E. D., Prowant B. F., Fruto L. V., Nolph K. D. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980 Jan;92(1):7–13. doi: 10.7326/0003-4819-92-1-7. [DOI] [PubMed] [Google Scholar]
  217. Ryan-Poirier K., Patrick C. C. Cervical adenitis caused by Staphylococcus epidermidis. J Clin Microbiol. 1993 Feb;31(2):426–427. doi: 10.1128/jcm.31.2.426-427.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Ryffel C., Kayser F. H., Berger-Bächi B. Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob Agents Chemother. 1992 Jan;36(1):25–31. doi: 10.1128/aac.36.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. SMITH I. M., BEALS P. D., KINGSBURY K. R., HASENCLEVER H. F. Observations on Staphylococcus albus septicemia in mice and men. AMA Arch Intern Med. 1958 Sep;102(3):375–388. doi: 10.1001/archinte.1958.00030010375005. [DOI] [PubMed] [Google Scholar]
  220. Sanchez M. L., Wenzel R. P., Jones R. N. In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic. Antimicrob Agents Chemother. 1992 Apr;36(4):873–875. doi: 10.1128/aac.36.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Schwalbe R. S., Ritz W. J., Verma P. R., Barranco E. A., Gilligan P. H. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis. 1990 Jan;161(1):45–51. doi: 10.1093/infdis/161.1.45. [DOI] [PubMed] [Google Scholar]
  222. Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987 Apr 9;316(15):927–931. doi: 10.1056/NEJM198704093161507. [DOI] [PubMed] [Google Scholar]
  223. Scriver S. R., Willey B. M., Low D. E., Simor A. E. Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens. Eur J Clin Microbiol Infect Dis. 1992 Jul;11(7):646–652. doi: 10.1007/BF01961677. [DOI] [PubMed] [Google Scholar]
  224. Shuttleworth R., Colby W. D. Staphylococcus lugdunensis endocarditis. J Clin Microbiol. 1992 Aug;30(8):1948–1952. doi: 10.1128/jcm.30.8.1948-1952.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Sidebottom D. G., Freeman J., Platt R., Epstein M. F., Goldmann D. A. Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci in neonatal intensive care. J Clin Microbiol. 1988 Apr;26(4):713–718. doi: 10.1128/jcm.26.4.713-718.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Singh V. R., Raad I. Fatal Staphylococcus saprophyticus native valve endocarditis in an intravenous drug addict. J Infect Dis. 1990 Sep;162(3):783–784. doi: 10.1093/infdis/162.3.783. [DOI] [PubMed] [Google Scholar]
  227. Smith K. R., Cobbs C. G. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):55–58. doi: 10.1007/BF01971273. [DOI] [PubMed] [Google Scholar]
  228. Stamm W. E. Protocol for diagnosis of urinary tract infection: reconsidering the criterion for significant bacteriuria. Urology. 1988 Aug;32(2 Suppl):6–12. [PubMed] [Google Scholar]
  229. Stout R. D., Ferguson K. P., Li Y. N., Lambe D. W., Jr Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect Immun. 1992 Mar;60(3):922–927. doi: 10.1128/iai.60.3.922-927.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Stratton C. W., Gelfand M. S., Gerberding J. L., Chambers H. F. Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrob Agents Chemother. 1990 Sep;34(9):1780–1782. doi: 10.1128/aac.34.9.1780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Suzuki E., Hiramatsu K., Yokota T. Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrob Agents Chemother. 1992 Feb;36(2):429–434. doi: 10.1128/aac.36.2.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Switalski L. M., Rydén C., Rubin K., Ljungh A., Hök M., Wadström T. Binding of fibronectin to Staphylococcus strains. Infect Immun. 1983 Nov;42(2):628–633. doi: 10.1128/iai.42.2.628-633.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. TORRES PEREIRA A. Coagulase-negative strains of staphylococcus possessing antigen 51 as agents of urinary infection. J Clin Pathol. 1962 May;15:252–253. doi: 10.1136/jcp.15.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Takeda S., Pier G. B., Kojima Y., Tojo M., Muller E., Tosteson T., Goldmann D. A. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 1991 Dec;84(6):2539–2546. doi: 10.1161/01.cir.84.6.2539. [DOI] [PubMed] [Google Scholar]
  235. Tanasupawat S., Hashimoto Y., Ezaki T., Kozaki M., Komagata K. Staphylococcus piscifermentans sp. nov., from fermented fish in Thailand. Int J Syst Bacteriol. 1992 Oct;42(4):577–581. doi: 10.1099/00207713-42-4-577. [DOI] [PubMed] [Google Scholar]
  236. Tesch W., Ryffel C., Strässle A., Kayser F. H., Berger-Bächi B. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2'. Antimicrob Agents Chemother. 1990 Sep;34(9):1703–1706. doi: 10.1128/aac.34.9.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Thomson-Carter F. M., Carter P. E., Pennington T. H. Differentiation of staphylococcal species and strains by ribosomal RNA gene restriction patterns. J Gen Microbiol. 1989 Jul;135(7):2093–2097. doi: 10.1099/00221287-135-7-2093. [DOI] [PubMed] [Google Scholar]
  238. Thomson-Carter F. M., Pennington T. H. Characterization of coagulase-negative staphylococci by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analyses. J Clin Microbiol. 1989 Oct;27(10):2199–2203. doi: 10.1128/jcm.27.10.2199-2203.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Thomson K. S., Sanders C. C., Hayden M. E. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. Antimicrob Agents Chemother. 1991 Nov;35(11):2329–2334. doi: 10.1128/aac.35.11.2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Timmerman C. P., Fleer A., Besnier J. M., De Graaf L., Cremers F., Verhoef J. Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene. Infect Immun. 1991 Nov;59(11):4187–4192. doi: 10.1128/iai.59.11.4187-4192.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Tojo M., Yamashita N., Goldmann D. A., Pier G. B. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988 Apr;157(4):713–722. doi: 10.1093/infdis/157.4.713. [DOI] [PubMed] [Google Scholar]
  242. Tollefson D. F., Bandyk D. F., Kaebnick H. W., Seabrook G. R., Towne J. B. Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses. Arch Surg. 1987 Jan;122(1):38–43. doi: 10.1001/archsurg.1987.01400130044006. [DOI] [PubMed] [Google Scholar]
  243. Torres Pereira A., Melo Cristino J. A. Phage typing of Staphylococcus saprophyticus. Epidemiol Infect. 1991 Dec;107(3):557–563. doi: 10.1017/s0950268800049256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Ubukata K., Nonoguchi R., Song M. D., Matsuhashi M., Konno M. Homology of mecA gene in methicillin-resistant Staphylococcus haemolyticus and Staphylococcus simulans to that of Staphylococcus aureus. Antimicrob Agents Chemother. 1990 Jan;34(1):170–172. doi: 10.1128/aac.34.1.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Veach L. A., Pfaller M. A., Barrett M., Koontz F. P., Wenzel R. P. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol. 1990 Sep;28(9):2064–2068. doi: 10.1128/jcm.28.9.2064-2068.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. WILSON T. S., STUART R. D. STAPHYLOCOCCUS ALBUS IN WOUND INFECTION AND IN SEPTICEMIA. Can Med Assoc J. 1965 Jul 3;93:8–16. [PMC free article] [PubMed] [Google Scholar]
  247. Wadström T. Molecular aspects of bacterial adhesion, colonization, and development of infections associated with biomaterials. J Invest Surg. 1989;2(4):353–360. doi: 10.3109/08941938909018261. [DOI] [PubMed] [Google Scholar]
  248. Wallmark G., Arremark I., Telander B. Staphylococcus saprophyticus: a frequent cause of acute urinary tract infection among female outpatients. J Infect Dis. 1978 Dec;138(6):791–797. doi: 10.1093/infdis/138.6.791. [DOI] [PubMed] [Google Scholar]
  249. Watanakunakorn C. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. J Antimicrob Chemother. 1988 Sep;22(3):321–324. doi: 10.1093/jac/22.3.321. [DOI] [PubMed] [Google Scholar]
  250. Wedrén H. On chronic prostatitis with special studies of Staphylococcus epidermidis. Scand J Urol Nephrol Suppl. 1989;123:1–36. [PubMed] [Google Scholar]
  251. Welch D. F. Applications of cellular fatty acid analysis. Clin Microbiol Rev. 1991 Oct;4(4):422–438. doi: 10.1128/cmr.4.4.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Westblom T. U., Gorse G. J., Milligan T. W., Schindzielorz A. H. Anaerobic endocarditis caused by Staphylococcus saccharolyticus. J Clin Microbiol. 1990 Dec;28(12):2818–2819. doi: 10.1128/jcm.28.12.2818-2819.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. Whyte W., Carson W., Hambraeus A. Methods for calculating the efficiency of bacterial surface sampling techniques. J Hosp Infect. 1989 Jan;13(1):33–41. doi: 10.1016/0195-6701(89)90093-5. [DOI] [PubMed] [Google Scholar]
  254. Widmer A. F., Nettleman M., Flint K., Wenzel R. P. The clinical impact of culturing central venous catheters. A prospective study. Arch Intern Med. 1992 Jun;152(6):1299–1302. [PubMed] [Google Scholar]
  255. Wilcox M. H., Finch R. G., Smith D. G., Williams P., Denyer S. P. Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber. J Antimicrob Chemother. 1991 May;27(5):577–587. doi: 10.1093/jac/27.5.577. [DOI] [PubMed] [Google Scholar]
  256. Wilcox M. H., Hussain M., Faulkner M. K., White P. J., Spencer R. C. Slime production and adherence by coagulase-negative staphylococci. J Hosp Infect. 1991 Aug;18(4):327–332. doi: 10.1016/0195-6701(91)90194-d. [DOI] [PubMed] [Google Scholar]
  257. Wilton J., Jung K., Vedin I., Aronsson B., Flock J. I. Comparative evaluation of a new molecular method for typing Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):515–521. doi: 10.1007/BF01960806. [DOI] [PubMed] [Google Scholar]
  258. Wolfson J. S., Hooper D. C. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev. 1989 Oct;2(4):378–424. doi: 10.1128/cmr.2.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Wood C. A., Sewell D. L., Strausbaugh L. J. Vertebral osteomyelitis and native valve endocarditis caused by Staphylococcus warneri. Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):261–263. doi: 10.1016/0732-8893(89)90024-2. [DOI] [PubMed] [Google Scholar]
  260. Woods G. L., Hall G. S., Rutherford I., Pratt K. J., Knapp C. C. Detection of methicillin-resistant Staphylococcus epidermidis. J Clin Microbiol. 1986 Sep;24(3):349–352. doi: 10.1128/jcm.24.3.349-352.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Zimmerman R. J., Kloos W. E. Comparative zone electrophoresis of esterases of Staphylococcus species isolated from mammalian skin. Can J Microbiol. 1976 Jun;22(6):771–779. doi: 10.1139/m76-113. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES